Skip to main navigation Skip to search Skip to main content

LncRNAs as potential therapeutic targets in thyroid cancer

  • Zeeshan Javed
  • , Faiez Ahmed Shah
  • , Sadegh Rajabi
  • , Qamar Raza
  • , Zaheer Iqbal
  • , Mukhtar Ullah
  • , Touqeer Ahmad
  • , Bahare Salehi
  • , Mehdi Sharifi-Rad
  • , Raffaele Pezzani
  • , Farooq Yaqoob
  • , Haleema Sadia
  • , Marcello Iriti
  • , Javad Sharifi-Rad
  • , William C. Cho

Research output: Contribution to journalReview articlepeer-review

30 Scopus citations

Abstract

Thyroid cancer (TC) is the most common cancer of endocrine system. TC can be subdivided into 4 different entities, papillary, follicular, medullary and anaplastic thyroid cancer. Among them, anaplastic thyroid cancer has the poorest prognosis. Exploring new therapeutic approach may entail favorable prediction as well as increasing overall survival rate of patients. Long non-coding RNAs (lncRNAs), have vast implications in different cancer types. Although they are not transcribed into proteins, they can act as a harness in regulating a plethora of biological functions. They have been implicated in a decisive role in gene expression via modulation of both coding and non-coding RNAs. This article discuss the multi-facet role of lncRNA in thyroid cancer biology.

Original languageEnglish
Pages (from-to)281-287
Number of pages7
JournalAsian Pacific Journal of Cancer Prevention
Issue number2
DOIs
StatePublished - 2020
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Genetic alterations
  • LncRNA
  • Thyroid cancer
  • Treatment

Fingerprint

Dive into the research topics of 'LncRNAs as potential therapeutic targets in thyroid cancer'. Together they form a unique fingerprint.

Cite this